Tandem Autologous Transplantation Can Overcome the Poor Prognosis of Double-Hit Multiple Myeloma Patients With 1q21 Gain/Amp and t(4;14)

被引：0
|
作者：
Huang, Beihui [1 ]
Li, Juan [1 ]
Wang, Xiuju [2 ]
Huang, Hongming [3 ]
Xu, Xiaojun [4 ]
Wu, Bingyi [5 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[3] Nantong Univ, Affiliated Hosp, Nantong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 7, Guangzhou, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-339
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [21] Treatment efficacy for relapsed/refractory multiple myeloma patients with gain/amplification of 1q21
    Zhou, Xia
    Wu, Hongying
    Hao, Lumei
    Wei, Liyan
    Li, Xuemei
    Yin, Junjing
    Yu, Qianru
    Xie, Zhanzhi
    Zhong, Yuping
    CHINESE MEDICAL JOURNAL, 2025, 138 (07) : 871 - 873
  • [22] Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
    Weinhold, Niels
    Kirn, Desiree
    Seckinger, Anja
    Hielscher, Thomas
    Granzow, Martin
    Bertsch, Uta
    Egerer, Gerlinde
    Salwender, Hans
    Blau, Igor W.
    Weisel, Katja
    Hillengass, Jens
    Raab, Marc S.
    Hose, Dirk
    Goldschmidt, Hartmut
    Jauch, Anna
    HAEMATOLOGICA, 2016, 101 (03) : E116 - E119
  • [23] The independent adverse prognostic significance of 1q21 gain in newly diagnosed multiple myeloma patients
    Fu, Chengcheng
    You, Hongying
    Yan, Shuang
    Pan, Jinlan
    Yao, Weiqin
    Shang, Jingjing
    Shi, Xiaolan
    Jin, Song
    Yan, Lingzhi
    Wu, Deipei
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S70 - S70
  • [24] Gain(1)(q21) Defines Group of Newly Diagnosed Multiple Myeloma Patients with Poor Prognosis.
    Nemec, Pavel
    Greslikova, Henrieta
    Zaoralova, Romana
    Smetana, Jan
    Filkova, Hana
    Dementyeva, Elena
    Kupska, Renata
    Berankova, Kristina
    Mikulasova, Aneta
    Pour, Ludek
    Zahradova, Lenka
    Kuglik, Petr
    Hajek, Roman
    BLOOD, 2009, 114 (22) : 1102 - 1103
  • [25] Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients
    Wang, Tongtong
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024, 38 (17-18)
  • [26] ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
    Wu, Chuan
    Yang, Ting
    Liu, Yingmin
    Lu, Yicheng
    Yang, Yanping
    Liu, Xiaobo
    Liu, Xuelian
    Ye, Long
    Sun, Yue
    Wang, Xue
    Li, Qingchao
    Yang, Peiyu
    Yu, Xiaoyuan
    Gao, Sujun
    Kumar, Shaji
    Jin, Fengyan
    Dai, Yun
    Li, Wei
    CANCER MEDICINE, 2018, 7 (08): : 3899 - 3911
  • [27] Adverse effects of double-hit combining ISS-Ⅲ stage and 1q gain or del(17p) on prognosis of patients with newly diagnosed multiple myeloma
    刘雪莲
    China Medical Abstracts(Internal Medicine), 2020, 37 (02) : 108 - 109
  • [28] The Independent Adverse Prognostic Significance of 1q21 Gain/Amplification in Newly Diagnosed Multiple Myeloma Patients
    You, Hongying
    Jin, Song
    Wu, Chunxiao
    Wang, Qingqing
    Yan, Shuang
    Zhai, Yingying
    Yao, Weiqin
    Shi, Xiaolan
    Shang, Jingjing
    Yan, Lingzhi
    Yao, Ying
    Wang, Jing
    Wang, Panfeng
    Pan, Jinlan
    Wu, Depei
    Fu, Chengcheng
    BLOOD, 2022, 140 : 10056 - 10057
  • [29] The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
    You, Hongying
    Jin, Song
    Wu, Chunxiao
    Wang, Qingqing
    Yan, Shuang
    Yao, Weiqin
    Shi, Xiaolan
    Shang, Jingjing
    Yan, Lingzhi
    Yao, Ying
    Wang, Jing
    Wang, Panfeng
    Pan, Jinlan
    Wu, Depei
    Fu, Chengcheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant
    Chang, H
    Sloan, S
    Li, D
    Zhuang, LH
    Yi, QL
    Chen, CI
    Reece, D
    Chun, K
    Stewart, AK
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (01) : 64 - 68
12345